Based on news reporting.
Merck is planning to cut jobs and reduce costs in response to weak demand for its Gardasil vaccine in China. The company has indicated that these layoffs are part of a broader strategy to address declining sales and improve operational efficiency. While specific numbers of affected employees have not been disclosed, the decision reflects ongoing challenges in the market. Merck's actions highlight the impact of fluctuating demand on its workforce and operational plans.
Merck & Co., Inc. cut 6,000 jobs.
That is roughly 8.6% of the 70,000 people Merck & Co., Inc. employs.
LayoffTalk has tracked 40 layoff events at Merck & Co., Inc. since October 2023, affecting a combined 14,671 employees.
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Estimated figure based on news reporting. Not yet confirmed by Merck & Co., Inc..
Share your story anonymously — it helps others reading this feel less alone.
Share your story →Recent tracked events at this company.